Fosnetupitant Chloride Hydrochloride; Palonosetron Hydrochloride Patent Expiration
Fosnetupitant Chloride Hydrochloride; Palonosetron Hydrochloride is Used for preventing chemotherapy-induced nausea and vomiting in adults. It was first introduced by Helsinn Healthcare Sa
Fosnetupitant Chloride Hydrochloride; Palonosetron Hydrochloride Patents
Given below is the list of patents protecting Fosnetupitant Chloride Hydrochloride; Palonosetron Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Akynzeo | US10208073 | Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulator | May 23, 2032 | Helsinn Hlthcare |
| Akynzeo | US10624911 | Physiologically balanced injectable formulations of fosnetupitant | Jun 02, 2037 | Helsinn Hlthcare |
| Akynzeo | US10717721 | Substituted piperaziniums for the treatment of emesis | May 23, 2032 | Helsinn Hlthcare |
| Akynzeo | US10828297 | Compositions and methods for treating centrally mediated nausea and vomiting | Dec 17, 2030 | Helsinn Hlthcare |
| Akynzeo | US11312698 | Fosnetupitant chloride hydrochloride having improved stability | May 23, 2032 | Helsinn Hlthcare |
| Akynzeo | US11529362 | Physiologically balanced injectable formulations of fosnetupitant | Jun 02, 2037 | Helsinn Hlthcare |
| Akynzeo | US8426450 | Substituted 4-phenyl pyridines having anti-emetic effect | May 23, 2032 | Helsinn Hlthcare |
| Akynzeo | US8895586 | Methods of treating emesis | May 23, 2032 | Helsinn Hlthcare |
| Akynzeo | US9186357 | Compositions and methods for treating centrally mediated nausea and vomiting | Nov 18, 2030 | Helsinn Hlthcare |
| Akynzeo | US9403772 | 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator | May 23, 2032 | Helsinn Hlthcare |
| Akynzeo | US9908907 | Substituted piperaziniums for the treatment of emesis | May 23, 2032 | Helsinn Hlthcare |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳